Position Summary Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas…

Position Summary Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas…

Position Summary The Regeneron Genetics Center (RGC) is a wholly-owned subsidiary of the Company, whose goals are to apply large scale human genetics to identify new drug targets and to guide the development of therapeutics programs and precision medicine. Building upon Regeneron’s strengths in mouse genetics and genetics-driven drug discovery and development, the RGC specializes…

Position Summary Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas…

Passionate about using complex data to make an impact in the world of cancer? With the advent of genomic sequencing, we can finally decode and process our genetic makeup. We now have more data than ever before but healthcare ecosystem doesn’t have the infrastructure or expertise to make sense of said data. Here at Tempus,…

Passionate about making a difference in the world of cancer genomics? With the advent of genomic sequencing, we can finally decode and process our genetic makeup. We now have more data than ever before but providers don’t have the infrastructure or expertise to make sense of said data. Here at Tempus, we believe the greatest…

Passionate about making a difference in the world of cancer genomics? With the advent of genomic sequencing, we can finally decode and process our genetic makeup. We now have more data than ever before but providers don’t have the infrastructure or expertise to make sense of said data. Here at Tempus, we believe the greatest…

Passionate about making a difference in the world of cancer genomics? With the advent of genomic sequencing, we can finally decode and process our genetic makeup. We now have more data than ever before but providers don’t have the infrastructure or expertise to make sense of said data. Here at Tempus, we believe the greatest…

We believe conquering cancer is a big data problem. That’s why we built the world’s leading comprehensive liquid biopsy. This non-invasive tool for accessing and sequencing tumor DNA is used by thousands of oncologists to help tens of thousands of advanced cancer patients. We believe the boom in cancer data acquisition we helped launch will…

Roche is the world leader in in-vitro diagnostics (IVD) and tissue-based cancer diagnostics and a front-runner in diabetes management. Roche Sequencing is seeking a talented Bioinformatics scientist to collaborate with experimentalists on computational analyses and to build the underlying analysis algorithms that enable the approval of next-generation sequencing (NGS) IVDs to impact patients through personalized…